Veklury (remdesivir) for injection recall
FDA recall D-0005-2025 · initiated Sep 19, 2024
Gilead Sciences, Inc. recalled Veklury (remdesivir) for injection in Sep 2024 — an FDA Class I recall (D-0005-2025) because Presence of Particulate Matter: Presence of glass particle.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Presence of Particulate Matter: Presence of glass particle.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 105,000 vials
Details
- Product
- Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
- Recalling company
- Gilead Sciences
- Classification
- Class I
- Status
- Terminated
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the U.S.A.
- Initiated
- Sep 19, 2024
- FDA report date
- Oct 9, 2024
This recall is linked to a product we cover: Veklury →
Frequently asked
- Was Veklury (remdesivir) for injection recalled?
- Gilead Sciences, Inc. recalled Veklury (remdesivir) for injection in Sep 2024 — an FDA Class I recall (D-0005-2025) because Presence of Particulate Matter: Presence of glass particle. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was Veklury (remdesivir) for injection recalled?
- Per the FDA enforcement record, the reason for recall D-0005-2025 was: Presence of Particulate Matter: Presence of glass particle.
- Is a recalled Veklury (remdesivir) for injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Veklury (remdesivir) for injection are affected?
- Distributed: Nationwide in the U.S.A.. The recall covers these lots — Lot: 47035CFA, Exp. 11/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0005-2025.